Patents by Inventor Ramakrishna SAMUDRALA

Ramakrishna SAMUDRALA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SANGUINARINE ANALOG PP2C INHIBITORS FOR CANCER TREATMENT
    Publication number: 20170240558
    Abstract: Sanguinarine analogs as PP2C inhibitors are disclosed for the treatment of various cancers, as well as methods of synthesizing such analogs.
    Type: Application
    Filed: May 8, 2017
    Publication date: August 24, 2017
    Applicant: Lixte Biotechnology, Inc.
    Inventors: John S. KOVACH, Francis JOHNSON, Ramakrishna SAMUDRALA
  • PROTEIN PHOSPHATASE INHIBITORS THAT CROSS THE BLOOD BRAIN BARRIER
    Publication number: 20160264593
    Abstract: The present invention provides a method for in vivo delivery of endothal to a target cell in a subject, the method comprising administering to the subject a compound having the structure: Formula (I).
    Type: Application
    Filed: November 14, 2014
    Publication date: September 15, 2016
    Inventors: John S. Kovach, Francis Johnson, Ramakrishna Samudrala, Ramesh C. Gupta
  • SANGUINARINE ANALOG PP2C INHIBITORS FOR CANCER TREATMENT
    Publication number: 20160009727
    Abstract: Sanguinarine analogs as PP2C inhibitors are disclosed for the treatment of various cancers, as well as methods of synthesizing such analogs.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 14, 2016
    Applicant: Lixte Biotechnology, Inc.
    Inventors: John S. KOVACH, Francis JOHNSON, Ramakrishna SAMUDRALA